Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-042091)

Filing Details

Accession Number:: 0001104659-21-042091
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-26 10:27:04
Reporting Period:: 2021-03-16

Accepted Time:: 2021-03-26 10:27:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534248	Chemomab Therapeutics Ltd.	CMMB	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1840006	Harris Neil Cohen	C/O Chemomab Therapeutics Ltd., 1 Kendall Sq, Bldg 1400E, Ste 14-105 Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
American Depositary Shares	Acquisiton	2021-03-16	2,409	$41.51	2,409	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
American Depositary Shares	Option to Purchase American Depositary Shares	Acquisiton	2021-03-16	688	$0.00	688	$13.17

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
688		2030-03-15	No	4	P	Direct

Footnotes

The Reporting Person acquired, in a private placement transaction, 1,397 American Depositary Shares and received an additional 1,011 American Depositary Shares pursuant to anti-dilution rights.
These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service.